BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Pathology and Oncology Research Publishes Landmark Phase 3 Study: Multikine Immunotherapy Significantly Improves Survival and Quality of Life in Head and Neck Cancer Patients

    Recent advancements in cancer immunotherapy have brought promising news for patients…
    BioTech Health X
    • March 24, 2025
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Aptose Biosciences (APTO) Stock Soars 31.50%: A Penny Stock on the Rise

    • BioTech Health X
    • February 23, 2025

    CEL-SCI Corporation: Leading the Future of Cancer Immunotherapy with Multikine®

    • BioTech Health X
    • February 20, 2025

    Ginkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024

    • BioTech Health X
    • February 8, 2025

    Hyperfine (HYPR)’s Swoop® Portable MRI: Transforming Emergency Neurological Care

    • BioTech Health X
    • February 8, 2025

    Most Trending
    Stories

    Biotech NewsPathology and Oncology Research Publishes Landmark Phase 3 Study: Multikine Immunotherapy Significantly Improves Survival and Quality of Life in Head and Neck Cancer Patients

    • BioTech Health X
    • March 24, 2025

    Biotech NewsAptose Biosciences (APTO) Stock Soars 31.50%: A Penny Stock on the Rise

    • BioTech Health X
    • February 23, 2025

    Biotech NewsCEL-SCI Corporation: Leading the Future of Cancer Immunotherapy with Multikine®

    • BioTech Health X
    • February 20, 2025

    Biotech NewsGinkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024

    • BioTech Health X
    • February 8, 2025

    Biotech NewsHyperfine (HYPR)’s Swoop® Portable MRI: Transforming Emergency Neurological Care

    • BioTech Health X
    • February 8, 2025

    Pathology and Oncology Research Publishes Landmark Phase 3 Study: Multikine Immunotherapy Significantly Improves Survival and Quality of Life in Head and Neck Cancer Patients

    • BioTech Health X
    • March 24, 2025
    Recent advancements in cancer immunotherapy have brought promising news for patients battling head and neck squamous cell carcinoma…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Aptose Biosciences (APTO) Stock Soars 31.50%: A Penny Stock on the Rise

    • BioTech Health X
    • February 23, 2025
    Aptose Biosciences (APTO) is a clinical-stage precision oncology company dedicated to addressing unmet needs in hematologic malignancies. The…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    CEL-SCI Corporation: Leading the Future of Cancer Immunotherapy with Multikine®

    • BioTech Health X
    • February 20, 2025
    CEL-SCI Corporation is a biotechnology leader committed to revolutionizing cancer treatment through innovative immunotherapy approaches. Founded in 1983…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Ginkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024

    • BioTech Health X
    • February 8, 2025
    Founded in 2008 by a team of visionary scientists from MIT, Ginkgo Bioworks Holdings Inc. (DNA) has emerged…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Hyperfine (HYPR)’s Swoop® Portable MRI: Transforming Emergency Neurological Care

    • BioTech Health X
    • February 8, 2025
    Hyperfine Inc. (HYPR) is at the forefront of transforming brain imaging with its groundbreaking Swoop® Portable MRI System,…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Quantum-Si (QSI) Stock Soars: QSI Can Be the Future of Protein Sequencing

    • BioTech Health X
    • February 8, 2025
    Quantum-Si Incorporated (QSI) is a revolutionary life sciences company that is transforming the field of proteomics through cutting-edge…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Lan Su, COO of Lakeside Holding, Shares His Vision and Strategies for Charting New Horizons

    • BioTech Health X
    • January 27, 2025
    Biotech Health X recently had the opportunity to sit down with Lan Su, the newly appointed Chief Operating…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Voyager Therapeutics (VYGR) Reports $24.6M in Q3 2024 Collaboration Revenues

    • BioTech Health X
    • January 19, 2025
    Voyager Therapeutics Inc. (VYGR) is a pioneering biotechnology company at the forefront of developing innovative gene therapies for…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    aTyr Pharma (ATYR) Raises $19.4 Million to Support Drug Development and Clinical Trials

    • BioTech Health X
    • January 19, 2025
    aTyr Pharma Inc. (ATYR) is a pioneering clinical-stage biopharmaceutical company dedicated to developing novel, first-in-class therapies for patients…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Aquestive Therapeutics (AQST) Reports Strong Q3 2024 Financial Results with 4% Revenue Growth

    • BioTech Health X
    • January 19, 2025
    Aquestive Therapeutics Inc. (AQST) is a cutting-edge pharmaceutical company dedicated to transforming the way medicines are delivered to…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    The Next Big Player in Immuno-Oncology: iTeos Therapeutics (ITOS)

    • BioTech Health X
    • January 19, 2025
    iTeos Therapeutics Inc. (ITOS), a clinical-stage biopharmaceutical company, is dedicated to pioneering the discovery and development of next-generation…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Protagonist Therapeutics (PTGX)Exceeds Revenue Estimates in Q3 2024

    • BioTech Health X
    • January 16, 2025
    Protagonist Therapeutics Inc. (PTGX) is an innovative clinical-stage biopharmaceutical company that specializes in the discovery and development of…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Madrigal Pharmaceuticals (MDGL): A Financial Powerhouse With $1.0 Billion Cash Position in 2024

    • BioTech Health X
    • January 16, 2025
    Madrigal Pharmaceuticals Inc. (MDGL) is a pioneering biopharmaceutical company focused on developing and commercializing novel, life-changing therapies for…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Kamada (KMDA) Reports Strong Q3 2024 Financial Results with $41.7M in Revenue

    • BioTech Health X
    • January 14, 2025
    Kamada Ltd. (KMDA) is a prominent global biopharmaceutical company that has established itself as a leader in the…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Gossamer Bio (GOSS) Reports Strong Q3 2024 Financial Results

    • BioTech Health X
    • January 14, 2025
    Gossamer Bio Inc. (GOSS) is a prominent clinical-stage biopharmaceutical company based in San Diego, California, committed to the…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Lakeside (LSH) Partners with Huiyu Pharmaceutical to Expand Global Oncology Drug Distribution

    • BioTech Health X
    • January 7, 2025
    Lakeside Holding Limited (LSH) is a dynamic U.S.-based cross-border supply chain solution provider, strategically headquartered in Itasca, Illinois.…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Sanara MedTech (SMTI) Achieves Record $21.7M Revenue in Q3 2024

    • BioTech Health X
    • January 2, 2025
    Sanara MedTech Inc. (SMTI), headquartered in Fort Worth, Texas, is a leading medical technology company dedicated to developing…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Aldeyra (ALDX) Reports $15.1M Q3 2024 Loss Amid R&D Investments

    • BioTech Health X
    • January 2, 2025
    Aldeyra Therapeutics Inc. (ALDX) is a clinical-stage biotechnology company that stands at the forefront of innovation in addressing…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0
    Recent Posts
    • Pathology and Oncology Research Publishes Landmark Phase 3 Study: Multikine Immunotherapy Significantly Improves Survival and Quality of Life in Head and Neck Cancer Patients
    • Aptose Biosciences (APTO) Stock Soars 31.50%: A Penny Stock on the Rise
    • CEL-SCI Corporation: Leading the Future of Cancer Immunotherapy with Multikine®
    • Ginkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024
    • Hyperfine (HYPR)’s Swoop® Portable MRI: Transforming Emergency Neurological Care
    Recent Comments
    • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
    • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
    • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
    • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
    Featured Posts
      • March 24, 2025
      Pathology and Oncology Research Publishes Landmark Phase 3 Study: Multikine Immunotherapy Significantly Improves Survival and Quality of Life in Head and Neck Cancer Patients
      • February 23, 2025
      Aptose Biosciences (APTO) Stock Soars 31.50%: A Penny Stock on the Rise
      • February 20, 2025
      CEL-SCI Corporation: Leading the Future of Cancer Immunotherapy with Multikine®
      • February 8, 2025
      Ginkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024
      • February 8, 2025
      Hyperfine (HYPR)’s Swoop® Portable MRI: Transforming Emergency Neurological Care
    Recent Posts
    • Galectin (GALT) Reports Improved Financial Performance in Q3 2024
      • December 31, 2024
    • Health In Tech (HIT) Achieves $289.8M Market Cap with Robust Growth Potential
      • December 31, 2024
    • Septerna (SEPN) Raises $302.6 Million in IPO to Fuel Drug Development Pipeline
      • December 29, 2024
    Categories
    • BioTech CEO Interviews (9)
    • Biotech Info (1)
    • Biotech News (128)
    • Uncategorized (1)
    Author
    Hello, I’m
    BioTech Health X
    Follow
    BioTech Health X
    Designed & Developed by BioTech Health X
    • About BioTech Health X
    • List of Modern Life Science Technologies
    • Biotechnology Company Directory – List of Major Biotech Companies
    • Contact Us
    • Privacy Policy

    Subscribe to
    Our Updates

    Back to top